On 24 August, Sayari reported that an Indian businessman, Jeetendra Harish Ielani, who pleaded guilty in December to drug importation, smuggling, and money laundering charges is connected to a broader network of India-based pharmaceutical companies, according to public records.  He had admitted imported into the US various drugs available only by prescription, including tapentadol, a Schedule II controlled substance, as well as tramadol, carisoprodol, and modafinil. The article says that the case is indicative of a growing trend, namely the emerging role of India as a key source of illicit synthetic drugs, along with licit drugs sold illegally.

Author: raytodd2017

Chartered Legal Executive and former senior manager with Isle of Man Customs and Excise, where I was (amongst other things) Sanctions Officer (for UN/EU sanctions), Export Licensing Officer and Manager of the Legal-Library & Collectorate Support Section

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s